agilon health, inc.
AGL
$0.65
-$0.01-1.99%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.87B | 5.89B | 5.98B | 6.05B | 5.58B |
| Total Other Revenue | 11.97M | 12.32M | 12.56M | 12.82M | 12.11M |
| Total Revenue | 5.89B | 5.90B | 5.99B | 6.06B | 5.59B |
| Cost of Revenue | 5.99B | 6.01B | 6.01B | 6.06B | 5.65B |
| Gross Profit | -107.61M | -104.13M | -19.53M | 4.84M | -51.77M |
| SG&A Expenses | 233.61M | 243.18M | 255.76M | 264.34M | 269.12M |
| Depreciation & Amortization | 28.12M | 26.91M | 25.50M | 24.46M | 22.70M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.25B | 6.28B | 6.29B | 6.34B | 5.94B |
| Operating Income | -369.34M | -374.21M | -300.78M | -283.96M | -343.59M |
| Income Before Tax | -321.21M | -327.70M | -253.63M | -248.83M | -311.03M |
| Income Tax Expenses | 1.68M | 1.43M | 1.78M | 1.45M | -39.00K |
| Earnings from Continuing Operations | -322.90 | -329.12 | -255.41 | -250.28 | -310.99 |
| Earnings from Discontinued Operations | 14.64M | 13.46M | 13.46M | -9.82M | -73.81M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00 | 0.00 | -20.00K | -50.00K | 1.00K |
| Net Income | -308.26M | -315.66M | -241.98M | -260.15M | -384.79M |
| EBIT | -369.34M | -374.21M | -300.78M | -283.96M | -343.59M |
| EBITDA | -341.22M | -347.30M | -275.28M | -259.49M | -320.89M |
| EPS Basic | -0.75 | -0.77 | -0.59 | -0.63 | -0.94 |
| Normalized Basic EPS | -0.47 | -0.49 | -0.38 | -0.37 | -0.47 |
| EPS Diluted | -0.75 | -0.77 | -0.59 | -0.63 | -0.94 |
| Normalized Diluted EPS | -0.47 | -0.49 | -0.38 | -0.37 | -0.47 |
| Average Basic Shares Outstanding | 1.65B | 1.65B | 1.65B | 1.64B | 1.64B |
| Average Diluted Shares Outstanding | 1.65B | 1.65B | 1.65B | 1.64B | 1.64B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |